Stocks in turmoil | JD Health (06618.HK) surged more than 6% after performance results, with operating profits nearly doubling year-on-year in the first quarter, and a variety of innovative medications were launched online.

According to the 36Kr Finance APP, JD Health (06618.HK) rose more than 6% after the performance announcement, with a 6.05% increase as of the time of writing, reaching 40.3 Hong Kong dollars, with a trading volume of 1.45 billion Hong Kong dollars.